
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India
New Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended granting permission to Biocon Biologics Ltd to manufacture and market Trastuzumab …